Cyclo Therapeutics's total assets for Q3 2024 were $5.25M, an increase of 11.36% from the previous quarter. CYTH total liabilities were $18.73M for the fiscal quarter, a 90.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.